Cepheid Company Profile (NASDAQ:CPHD)

About Cepheid

Cepheid logoCepheid is a molecular diagnostics company. The Company develops, manufactures and markets fully-integrated systems for testing in the Clinical and Non-Clinical markets. The Company's systems enable molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The Company's systems integrate these steps and analyze biological samples in test cartridges. Its primary offering is the GeneXpert system, which integrates sample preparation in addition to Deoxyribonucleic acid (DNA) amplification and detection. The GeneXpert system is designed for a range of user types ranging from reference laboratories and hospital central laboratories to satellite testing locations, such as emergency departments and intensive care units within hospitals, as well as physician offices and other alternate site laboratories. It also offers the SmartCycler system, which integrates DNA amplification and detection to allow rapid analysis of a sample.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Scientific & Technical Instruments
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: CPHD
  • CUSIP: 15670R10
Key Metrics:
  • Previous Close: $34.69
  • 50 Day Moving Average: $34.79
  • 200 Day Moving Average: $31.79
  • 52-Week Range: $25.09 - $53.19
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 56.87
  • P/E Growth: 5.26
  • Market Cap: $2.53B
  • Outstanding Shares: 73,007,000
  • Beta: 0.42
Additional Links:
Companies Related to Cepheid:

Analyst Ratings

Consensus Ratings for Cepheid (NASDAQ:CPHD) (?)
Ratings Breakdown: 9 Hold Ratings, 12 Buy Ratings
Consensus Rating:Buy (Score: 2.57)
Consensus Price Target: $40.08 (15.53% upside)

Analysts' Ratings History for Cepheid (NASDAQ:CPHD)
DateFirmActionRatingPrice TargetDetails
8/17/2016Jefferies GroupBoost Price TargetHold$28.00 -> $34.00View Rating Details
7/29/2016JPMorgan Chase & Co.Boost Price TargetNeutral$32.00 -> $35.00View Rating Details
6/29/2016Canaccord GenuityReiterated RatingHold$32.00View Rating Details
6/15/2016Morgan StanleyInitiated CoverageEqual Weight$30.00View Rating Details
4/30/2016Needham & Company LLCReiterated RatingBuyView Rating Details
4/1/2016Atlantic SecuritiesUpgradeNeutral -> OverweightView Rating Details
4/1/2016BTIG ResearchUpgradeNeutral -> Buy$42.00View Rating Details
3/28/2016WedbushLower Price TargetOutperform$58.00 -> $55.00View Rating Details
2/3/2016Cowen and CompanyReiterated RatingBuyView Rating Details
2/3/2016Robert W. BairdLower Price TargetOutperform$45.00 -> $40.00View Rating Details
2/3/2016Stifel NicolausLower Price TargetBuy$42.00 -> $38.00View Rating Details
2/3/2016Barclays PLCLower Price TargetEqual Weight$38.00 -> $36.00View Rating Details
2/3/2016Leerink SwannReiterated RatingMarket Perform$39.00 -> $33.00View Rating Details
1/6/2016Avondale PartnersInitiated CoverageOutperform$46.00View Rating Details
12/2/2015Wells Fargo & Co.DowngradeOutperform -> Market PerformView Rating Details
10/21/2015Craig HallumLower Price TargetBuy$52.00 -> $42.00View Rating Details
10/21/2015Evercore ISIUpgradeSell -> Hold$44.50 -> $32.50View Rating Details
10/21/2015MizuhoLower Price TargetBuy$60.00 -> $42.00View Rating Details
10/15/2015Citigroup Inc.Lower Price TargetBuy$62.00 -> $48.00View Rating Details
10/14/2015Piper Jaffray Cos.Reiterated RatingBuy$66.00 -> $62.00View Rating Details
10/14/2015Goldman Sachs Group Inc.Lower Price Target$53.00 -> $30.00View Rating Details
10/14/2015Raymond James Financial Inc.DowngradeOutperform -> Market PerformView Rating Details
7/26/2015MKM PartnersReiterated RatingBuy$65.00 -> $72.00View Rating Details
7/24/2015Evercore Partners Inc.Reiterated RatingHold -> SellView Rating Details
4/26/2015Cantor FitzgeraldReiterated RatingBuy$62.00View Rating Details
4/24/2015JMP SecuritiesBoost Price TargetMarket Outperform$58.00 -> $67.00View Rating Details
1/30/2015Oppenheimer Holdings Inc.Boost Price TargetOutperform$57.00 -> $60.00View Rating Details
12/30/2014William BlairReiterated RatingBuyView Rating Details
12/30/2014Bank of America Corp.UpgradeNeutral -> BuyView Rating Details
(Data available from 8/31/2014 forward)


Earnings History for Cepheid (NASDAQ:CPHD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/28/2016Q216($0.14)$0.05$145.82 million$146.00 millionViewListenView Earnings Details
4/28/2016Q116$0.01$0.08$140.35 million$144.80 millionViewN/AView Earnings Details
2/2/2016Q415($0.20)$0.07$146.95 million$147.00 millionViewN/AView Earnings Details
10/20/2015Q3($0.31)($0.13)$126.81 million$126.50 millionViewListenView Earnings Details
7/23/2015Q215($0.21)($0.06)$130.70 million$132.50 millionViewListenView Earnings Details
4/23/2015Q115($0.16)$0.01$125.50 million$132.60 millionViewN/AView Earnings Details
1/29/2015Q414($0.13)$0.11$125.34 million$131.50 millionViewN/AView Earnings Details
10/16/2014Q314($0.16)$0.06$110.10 million$115.20 millionViewListenView Earnings Details
7/17/2014Q214($0.13)$0.03$115.47 million$116.50 millionViewN/AView Earnings Details
4/17/2014Q114($0.17)($0.01)$104.90 million$106.90 millionViewN/AView Earnings Details
1/31/2014Q413($0.11)($0.15)$102.17 million$113.30 millionViewN/AView Earnings Details
10/17/2013Q313($0.11)($0.20)$93.70 million$100.10 millionViewN/AView Earnings Details
7/18/2013Q2 2013$0.04$0.02$92.57 million$96.00 millionViewN/AView Earnings Details
4/18/2013Q1 2013$0.10$0.11$89.12 million$91.90 millionViewN/AView Earnings Details
1/24/2013Q4 2012$0.11$0.20$92.87 million$92.40 millionViewN/AView Earnings Details
10/18/2012($0.07)($0.32)ViewN/AView Earnings Details
7/19/2012$0.11$0.11ViewN/AView Earnings Details
4/19/2012($0.01)($0.08)ViewN/AView Earnings Details
1/26/2012($0.02)($0.03)ViewN/AView Earnings Details
10/20/2011$0.02$0.03ViewN/AView Earnings Details
7/21/2011($0.01)$0.03ViewN/AView Earnings Details
4/20/2011($0.01)$0.01ViewN/AView Earnings Details
1/27/2011($0.02)$0.02ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Cepheid (NASDAQ:CPHD)
Current Year EPS Consensus Estimate: $-0.23 EPS
Next Year EPS Consensus Estimate: $0.61 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.26)($0.16)($0.21)
Q2 20163($0.20)($0.17)($0.18)
Q3 20163($0.18)($0.11)($0.15)
Q4 20162($0.03)($0.01)($0.02)
(Data provided by Zacks Investment Research)


Dividend History for Cepheid (NASDAQ:CPHD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Cepheid (NASDAQ:CPHD)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/17/2016Scott A CampbellVPSell287$36.16$10,377.92View SEC Filing  
8/4/2016Scott A CampbellVPSell746$36.71$27,385.66View SEC Filing  
5/3/2016Scott A CampbellVPSell2,058$27.90$57,418.20View SEC Filing  
5/2/2016Peter V FarrellEVPSell390$28.90$11,271.00View SEC Filing  
4/28/2016Peter V FarrellEVPSell390$36.30$14,157.00View SEC Filing  
4/25/2016John L BishopCEOSell110,000$35.50$3,905,000.00View SEC Filing  
3/10/2016Peter V FarrellEVPSell393$33.01$12,972.93View SEC Filing  
2/8/2016Warren C. Kocmond, Jr.COOSell292$28.53$8,330.76View SEC Filing  
2/1/2016Warren C. Kocmond, Jr.COOSell351$28.44$9,982.44View SEC Filing  
1/22/2016Warren C. Kocmond, Jr.COOSell157$33.16$5,206.12View SEC Filing  
12/10/2015Peter V. FarrellEVPSell394$31.67$12,477.98View SEC Filing  
11/20/2015Robert J EastonDirectorSell3,206$36.02$115,480.12View SEC Filing  
11/17/2015Robert J EastonDirectorSell2,724$34.84$94,904.16View SEC Filing  
11/12/2015Robert J EastonDirectorSell2,556$35.01$89,485.56View SEC Filing  
10/30/2015Peter V. FarrellEVPSell1,560$33.89$52,868.40View SEC Filing  
8/27/2015Peter V. FarrellEVPSell1,577$48.67$76,752.59View SEC Filing  
8/25/2015Cristina KepnerDirectorBuy10,000$47.78$477,800.00View SEC Filing  
6/26/2015Warren C Kocmond JrCOOSell9,375$61.52$576,750.00View SEC Filing  
4/29/2015Thomas L GutshallDirectorSell1,800$56.62$101,916.00View SEC Filing  
4/21/2015Joseph H SmithEVPSell91,866$54.51$5,007,615.66View SEC Filing  
4/20/2015John L BishopCEOSell100,000$55.20$5,520,000.00View SEC Filing  
2/25/2015Hollings RentonDirectorSell9,375$57.76$541,500.00View SEC Filing  
2/13/2015Dean O MortonDirectorSell12,500$58.51$731,375.00View SEC Filing  
2/3/2015Thomas D BrownDirectorSell12,500$56.29$703,625.00View SEC Filing  
1/30/2015Andrew MillerCFOSell6,677$57.64$384,862.28View SEC Filing  
1/12/2015Andrew MillerCFOSell11,719$56.65$663,881.35View SEC Filing  
1/12/2015David H PersingEVPSell5,000$56.90$284,500.00View SEC Filing  
1/12/2015Warren C Kocmond JrCOOSell4,688$57.00$267,216.00View SEC Filing  
1/5/2015Andrew MillerCFOSell2,250$54.95$123,637.50View SEC Filing  
1/5/2015Kerry FlomEVPSell8,694$54.21$471,301.74View SEC Filing  
11/19/2014Dean O MortonDirectorSell11,849$52.96$627,523.04View SEC Filing  
11/7/2014Hollings RentonDirectorSell9,375$51.07$478,781.25View SEC Filing  
10/31/2014Andrew MillerCFOSell12,167$53.84$655,071.28View SEC Filing  
10/31/2014David H PersingEVPSell20,000$53.34$1,066,800.00View SEC Filing  
10/31/2014Dean O MortonDirectorSell7,500$52.64$394,800.00View SEC Filing  
10/29/2014Kerry FlomEVPSell7,077$51.36$363,474.72View SEC Filing  
10/29/2014Thomas L GutshallDirectorSell12,500$51.63$645,375.00View SEC Filing  
10/28/2014David H PersingEVPSell15,000$51.51$772,650.00View SEC Filing  
10/3/2014Kerry FlomEVPSell1,271$44.52$56,584.92View SEC Filing  
8/7/2014Warren C Kocmond JrEVPSell324$38.69$12,535.56View SEC Filing  
7/14/2014Kerry FlomEVPSell2,812$49.72$139,812.64View SEC Filing  
7/3/2014Kerry FlomEVPSell1,282$48.97$62,779.54View SEC Filing  
5/29/2014Kerry FlomEVPSell4,265$45.49$194,014.85View SEC Filing  
5/22/2014Warren C Kocmond JrEVPSell1,300$42.38$55,094.00View SEC Filing  
4/29/2014Kerry FlomEVPSell2,660$42.38$112,730.80View SEC Filing  
4/25/2014John BishopCEOSell107,651$43.93$4,729,108.43View SEC Filing  
4/22/2014John BishopCEOSell42,349$46.11$1,952,712.39View SEC Filing  
4/22/2014Robert EastonDirectorSell12,500$45.59$569,875.00View SEC Filing  
4/3/2014Kerry FlomEVPSell1,621$51.55$83,562.55View SEC Filing  
4/1/2014Andrew MillerCFOSell4,688$52.78$247,432.64View SEC Filing  
3/13/2014Andrew MillerCFOSell17,265$55.55$959,070.75View SEC Filing  
1/31/2014Andrew MillerCFOSell63,375$53.10$3,365,212.50View SEC Filing  
1/31/2014John BishopCEOSell150,000$50.67$7,600,500.00View SEC Filing  
1/31/2014Joseph SmithEVPSell50,000$51.15$2,557,500.00View SEC Filing  
1/3/2014Kerry FlomEVPSell6,357$45.66$290,260.62View SEC Filing  
1/2/2014Andrew MillerCFOSell2,437$45.92$111,907.04View SEC Filing  
12/23/2013Kerry FlomEVPSell10,000$46.51$465,100.00View SEC Filing  
10/30/2013David H PersingVPSell5,000$41.35$206,750.00View SEC Filing  
10/29/2013Kerry FlomEVPSell2,660$40.50$107,730.00View SEC Filing  
10/24/2013Thomas L GutshallDirectorSell3,000$40.07$120,210.00View SEC Filing  
10/18/2013David H PersingVPSell20,000$40.59$811,800.00View SEC Filing  
9/24/2013Thomas GutshallDirectorSell3,000$38.97$116,910.00View SEC Filing  
9/18/2013David PersingVPSell5,000$39.34$196,700.00View SEC Filing  
9/16/2013David PersingVPSell5,000$38.95$194,750.00View SEC Filing  
9/6/2013David H PersingVPSell20,000$37.99$759,800.00View SEC Filing  
8/30/2013David PersingVPSell5,129$36.62$187,823.98View SEC Filing  
8/26/2013Thomas GutshallDirectorSell3,000$36.38$109,140.00View SEC Filing  
8/21/2013Robert EastonDirectorSell7,500$35.01$262,575.00View SEC Filing  
7/24/2013Thomas L GutshallDirectorSell3,000$34.18$102,540.00View SEC Filing  
6/24/2013Thomas L GutshallDirectorSell3,000$32.91$98,730.00View SEC Filing  
5/28/2013Andrew MillerCFOSell22,468$38.51$865,242.68View SEC Filing  
5/24/2013Thomas L GutshallDirectorSell3,000$37.90$113,700.00View SEC Filing  
5/13/2013Kerry FlomEVPSell6,832$39.76$271,640.32View SEC Filing  
3/25/2013Thomas L GutshallDirectorSell3,000$38.28$114,840.00View SEC Filing  
2/4/2013Joseph H SmithEVPSell38,400$36.20$1,390,080.00View SEC Filing  
12/24/2012Thomas L GutshallDirectorSell3,000$33.06$99,180.00View SEC Filing  
11/26/2012Thomas L GutshallDirectorSell7,778$31.94$248,429.32View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Cepheid (NASDAQ:CPHD)
mysmartrend.com logoShares of CPHD Up 21.8% Since Uptrend Call on Shares (NASDAQ:CPHD)
www.mysmartrend.com - August 25 at 9:19 AM
News IconThe Statistics Don't Lie: Cepheid (NASDAQ:CPHD) Earnings ... - The Voice Registrar (NASDAQ:CPHD)
voiceregistrar.com - August 24 at 4:20 PM
capitalcube.com logoETF’s with exposure to Cepheid : August 23, 2016 (NASDAQ:CPHD)
www.capitalcube.com - August 23 at 4:30 PM
News IconInteresting CPHD Put And Call Options For October 21st (NASDAQ:CPHD)
www.stockoptionschannel.com - August 22 at 4:28 PM
News IconCepheid's (CPHD): Checklist Stock of the Friday - Hot Stocks Point (NASDAQ:CPHD)
www.hotstockspoint.com - August 22 at 4:28 PM
stocksdaily.net logoWhat Is Mean Rating On CEPHEID (NASDAQ:CPHD)? (NASDAQ:CPHD)
www.stocksdaily.net - August 19 at 8:28 PM
finance.yahoo.com logoMoving Average Crossover Alert: Cepheid (CPHD) (NASDAQ:CPHD)
finance.yahoo.com - August 19 at 10:52 AM
finance.yahoo.com logoCEPHEID Financials (NASDAQ:CPHD)
finance.yahoo.com - August 17 at 4:32 PM
mysmartrend.com logo21.0% Return Seen to Date on SmarTrend Cepheid Call (CPHD) (NASDAQ:CPHD)
www.mysmartrend.com - August 17 at 10:28 AM
fidaily.com logoColumbia Wanger Asset Management LLC Significantly Decreases Its Holdings in CEPHEID (CPHD) - Finance Daily (NASDAQ:CPHD)
www.fidaily.com - August 12 at 9:36 PM
capitalcube.com logoETF’s with exposure to Cepheid : August 11, 2016 (NASDAQ:CPHD)
www.capitalcube.com - August 11 at 4:28 PM
tradecalls.org logoCEPHEID (CPHD) Shares are Up 6.35% (NASDAQ:CPHD)
www.tradecalls.org - August 9 at 5:23 PM
mysmartrend.com logoCepheid Shares Up 24.2% Since SmarTrend's Buy Recommendation (CPHD) (NASDAQ:CPHD)
www.mysmartrend.com - August 9 at 5:23 PM
tradecalls.org logoCEPHEID (CPHD) Shares are Up 6.35% - Trade Calls (NASDAQ:CPHD)
www.tradecalls.org - August 9 at 10:51 AM
biz.yahoo.com logoCEPHEID Files SEC form 10-Q, Quarterly Report (NASDAQ:CPHD)
biz.yahoo.com - August 8 at 9:46 PM
streetupdates.com logoAnalysts Ranking Activities: CEPHEID (NASDAQ:CPHD) , Quantum Corporation (NYSE:QTM) - Street Updates (NASDAQ:CPHD)
www.streetupdates.com - August 8 at 4:28 PM
capitalcube.com logoCepheid :CPHD-US: Earnings Analysis: Q2, 2016 By the Numbers : August 8, 2016 (NASDAQ:CPHD)
www.capitalcube.com - August 8 at 4:28 PM
tradecalls.org logoRhenman Partners Asset Management Ab buys $9,568,000 stake in ... - Trade Calls (NASDAQ:CPHD)
www.tradecalls.org - August 6 at 10:58 AM
finance.yahoo.com logoCepheid to Webcast Upcoming Financial Presentations (NASDAQ:CPHD)
finance.yahoo.com - August 4 at 4:33 PM
cnbc.com logoCramer: Perfect stock to work in this environment (NASDAQ:CPHD)
www.cnbc.com - August 3 at 10:02 PM
streetupdates.com logoAnalyst's Valuable Buzzers: CDK Global, Inc. (NASDAQ:CDK ... - Street Updates (NASDAQ:CPHD)
www.streetupdates.com - August 3 at 4:30 PM
streetupdates.com logoAnalyst's Valuable Buzzers: CDK Global, Inc. (NASDAQ:CDK ... - Street Updates (NASDAQ:CPHD)
www.streetupdates.com - August 3 at 4:30 PM
equities.com logoCEPHEID (CPHD) is Trading Higher on Unusual Volume for August 01 - Equities.com (NASDAQ:CPHD)
www.equities.com - August 3 at 10:49 AM
finance.yahoo.com logoIDEXX (IDXX) Tops Q2 Earnings, Revenues, FY16 View Up (NASDAQ:CPHD)
finance.yahoo.com - August 3 at 10:48 AM
finance.yahoo.com logoCepheid (CPHD) Shares March Higher, Can It Continue? (NASDAQ:CPHD)
finance.yahoo.com - August 2 at 4:29 PM
seekingalpha.com logoCepheid: Maybe Not The End After All (NASDAQ:CPHD)
seekingalpha.com - August 2 at 9:08 AM
biz.yahoo.com logoCEPHEID Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Fi (NASDAQ:CPHD)
biz.yahoo.com - August 2 at 9:08 AM
nasdaq.com logoCepheid (CPHD) Looks Good: Stock Adds 8% in Session - Nasdaq (NASDAQ:CPHD)
www.nasdaq.com - August 1 at 4:18 PM
finance.yahoo.com logoCepheid (CPHD) Looks Good: Stock Adds 8% in Session (NASDAQ:CPHD)
finance.yahoo.com - August 1 at 8:25 AM
rttnews.com logoEARNINGS SUMMARY: Details of CEPHEID INC Q2 Earnings Report (NASDAQ:CPHD)
www.rttnews.com - July 30 at 10:58 AM
streetinsider.com logoCepheid (CPHD) Reports Q2 EPS of $0.05 (NASDAQ:CPHD)
www.streetinsider.com - July 30 at 10:58 AM
equities.com logoCEPHEID (CPHD) Jumps 8.04% on July 29 - Equities.com (NASDAQ:CPHD)
www.equities.com - July 29 at 9:48 PM
fidaily.com logoMorgan Stanley Starts Coverage on CEPHEID (CPHD) With An Initial Rating Of "Equal-weight" - Finance Daily (NASDAQ:CPHD)
www.fidaily.com - July 29 at 4:28 PM
nasdaq.com logoCepheid's (CPHD) Q2 Loss Narrower than Estimate, View Up - Nasdaq (NASDAQ:CPHD)
www.nasdaq.com - July 29 at 4:28 PM
finance.yahoo.com logoCepheid's (CPHD) Q2 Loss Narrower than Estimate, View Up (NASDAQ:CPHD)
finance.yahoo.com - July 29 at 3:09 PM
seekingalpha.com logoCepheid (CPHD) John L. Bishop on Q2 2016 Results - Earnings Call Transcript - Seeking Alpha (NASDAQ:CPHD)
seekingalpha.com - July 29 at 8:14 AM
finance.yahoo.com logoEdited Transcript of CPHD earnings conference call or presentation 28-Jul-16 9:00pm GMT (NASDAQ:CPHD)
finance.yahoo.com - July 28 at 9:00 PM
sg.finance.yahoo.com logoCepheid reports 2Q loss (NASDAQ:CPHD)
sg.finance.yahoo.com - July 28 at 6:37 PM
streetinsider.com logoCepheid (CPHD) Reports Q2 EPS of $0.05 - StreetInsider.com (NASDAQ:CPHD)
www.streetinsider.com - July 28 at 5:28 PM
biz.yahoo.com logoCepheid Earnings Call scheduled for 5:00 pm ET today (NASDAQ:CPHD)
biz.yahoo.com - July 28 at 5:00 PM
biz.yahoo.com logoQ2 2016 Cepheid Earnings Release - After Market Close (NASDAQ:CPHD)
biz.yahoo.com - July 28 at 7:07 AM
News IconIt's Earnings Time: What to Do with Cepheid (NASDAQ:CPHD) Stock - The Voice Registrar (NASDAQ:CPHD)
voiceregistrar.com - July 25 at 9:08 PM
ftsenews.co.uk logoCEPHEID (NASDAQ:CPHD) Updated Price Targets - FTSE News (NASDAQ:CPHD)
www.ftsenews.co.uk - July 21 at 4:27 PM
tmcnet.com logoTechnical Notes on Scientific & Technical Instruments' Stocks -- Trimble Navigation, Garmin, Keysight Technologies, and Cepheid (NASDAQ:CPHD)
www.tmcnet.com - July 20 at 11:17 AM
tradecalls.org logoShares of CEPHEID (CPHD) Drops by -1.89% - Trade Calls (NASDAQ:CPHD)
www.tradecalls.org - July 18 at 4:35 PM
publicnow.com logoCepheid Announces Results Of Validation Study For Use Of Xpert HPV In Primary Cervical Cancer Screening (NASDAQ:CPHD)
www.publicnow.com - July 12 at 8:23 AM
equities.com logoCEPHEID (CPHD) Jumps 6.47% on July 08 - Equities.com (NASDAQ:CPHD)
www.equities.com - July 9 at 5:59 AM
nasdaq.com logoCepheid (CPHD) Shares Cross Above 200 DMA - Nasdaq (NASDAQ:CPHD)
www.nasdaq.com - July 9 at 5:59 AM
nasdaq.com logoCepheid (CPHD) Shares Cross Above 200 DMA (NASDAQ:CPHD)
www.nasdaq.com - July 8 at 9:25 PM
News IconShares of CEPHEID (CPHD) Sees Large Outflow of Money - TheFounders Daily (NASDAQ:CPHD)
www.thefoundersdaily.com - July 8 at 4:25 PM


Cepheid (NASDAQ:CPHD) Chart for Wednesday, August, 31, 2016

Last Updated on 8/31/2016 by MarketBeat.com Staff